Age, primary tumor characteristics at diagnosis (clinical T classification, grade, hormone receptor status, ki67, and p53), and pathologic tumor characteristics (pathologic T classification, lymph node status, grade, hormone receptor status, ki67, and p53) did not statistically differ by residual disease HER2 status. This evidence concerns the gene MKI67 and neoplasm.